CAC40: euphoric with +1.5% but rise without any volume


(CercleFinance.com) – The Paris Stock Exchange soared from +1.5 to +1.6%, towards 6,580/6,590 points (the SBF-120 crossed again the 5,100): a score which reflects an apparent euphoria but such the differences are mainly explained by the absence of a seller counterpart (no one ‘stands in front of a funicular algo’ like the one identified from the pre-opening) on ​​this Pentecost day.
The volumes are completely anecdotal: less than 1,350 MnsE half an hour from closing… a sidereal vacuum.
Wall Street is recovering: the Dow Jones gains almost +1%, the Nasdaq +1.5% after a significant correction on Friday (unlike Paris which had fallen little but is recovering very strongly).

The rise of the day is all the more singular that no major publication is on the agenda (no publication this morning but quickly +100Pts of rise in Paris).

Moreover, buyers would forget all caution 48 hours before the meeting of the European Central Bank (ECB), which could begin to prepare investors for monetary tightening in the short term.

After the record inflation figures unveiled last week, the ECB appears under pressure to adopt a more restrictive monetary policy, with the possibility of a rate hike as of July.

Note that after nine consecutive weeks of decline, bitcoin gained more than 6%, to 31,400 USD, while Ethereum climbed by +6.7%: would this also be a sign of a return of appetite? for the risk?
On the foreign exchange front, the euro gained 0.1% against the greenback and is now trading against $1.0710 after climbing up to around 1.0750.

North Sea Brent stabilized around $120 a barrel (-0.3% to $119.8).

As for values, L’Oréal (+2.5%) is a major contributor to the rise in the CAC.
Euroapi gains +2.5% after the announcement of its first global employee shareholding plan, an operation which ‘aims to promote the feeling of belonging among employees and to associate them with the success and development of the group in the long term’ .
Within the SBF-120, Faurecia soars by almost +10% and digests the capital increase announced on Friday.

Transgene shares are on the rise on the Paris Stock Exchange on Monday following the presentation of data deemed ‘promising’ at the annual ASCO oncology congress on the evaluation of its personalized therapeutic vaccine in ovarian cancer and head and neck cancer.

Finally, Carrefour indicates that its board of directors decided last Friday to reduce the share capital by canceling 12,506,325 repurchased shares, representing approximately 1.6% of the share capital.

Copyright © 2022 CercleFinance.com. All rights reserved.

Did you like this article ? Share it with your friends with the buttons below.


Twitter


Facebook


LinkedIn


E-mail





Source link -85